Trial intelligence / Profile preview

Combizym for Malnutrition in Cirrhosis

NCT04057326Unknown

Sponsor
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Start
Aug 2019
Primary completion
Dec 2020
Modality
Replacement Enzymes
01

Overview

Randomised, double-blind trial in Malnutrition comparing Combizym with Placebo (2 arms). Primary endpoints: Mid-Arm Muscle Circumference at 180 days and Subjective Global Assessment at 180 days. Status: unknown.

02

Drugs

Aspergillus oryzae + Pancreatin
03

Conditions

Malnutrition

Beyond the preview

Go deeper on NCT04057326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04057326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call